ATE214399T1 - Mycobacteriumprotein und dessen verwendung - Google Patents

Mycobacteriumprotein und dessen verwendung

Info

Publication number
ATE214399T1
ATE214399T1 AT92911693T AT92911693T ATE214399T1 AT E214399 T1 ATE214399 T1 AT E214399T1 AT 92911693 T AT92911693 T AT 92911693T AT 92911693 T AT92911693 T AT 92911693T AT E214399 T1 ATE214399 T1 AT E214399T1
Authority
AT
Austria
Prior art keywords
proteins
pct
approximately
date
sec
Prior art date
Application number
AT92911693T
Other languages
English (en)
Inventor
Gilles Marchal
Felix Romain
Pascale Pescher
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE214399T1 publication Critical patent/ATE214399T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Gram-positive bacteria
    • C07K16/1289Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92911693T 1991-06-07 1992-06-05 Mycobacteriumprotein und dessen verwendung ATE214399T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9106970A FR2677365B1 (fr) 1991-06-07 1991-06-07 Proteines de mycobacterium et applications.
PCT/FR1992/000508 WO1992021758A1 (fr) 1991-06-07 1992-06-05 Proteines de mycobacterium et applications

Publications (1)

Publication Number Publication Date
ATE214399T1 true ATE214399T1 (de) 2002-03-15

Family

ID=9413612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911693T ATE214399T1 (de) 1991-06-07 1992-06-05 Mycobacteriumprotein und dessen verwendung

Country Status (10)

Country Link
US (2) US5962240A (de)
EP (1) EP0589943B1 (de)
JP (1) JPH06508513A (de)
AT (1) ATE214399T1 (de)
CA (1) CA2110389A1 (de)
DE (1) DE69232483T2 (de)
DK (1) DK0589943T3 (de)
ES (1) ES2170055T3 (de)
FR (1) FR2677365B1 (de)
WO (1) WO1992021758A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
BR9408135A (pt) 1993-11-23 1997-08-05 Univ California Produtos extra-celulares abundantes e processos para sua produção e uso
WO1996005223A1 (en) * 1994-08-12 1996-02-22 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
CA2230927A1 (en) * 1995-09-01 1997-03-13 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
EP1712629A3 (de) * 1995-09-01 2009-09-09 Corixa Corporation Verbindungen und Verfahren zur Diagnose von Tuberkulose
PT1398379E (pt) * 1995-09-01 2007-01-31 Corixa Corp Compostos para imunoterapia e diagnóstico de tuberculose
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
TR199901569T2 (xx) * 1996-10-11 2000-12-21 Corixa Corporation T�berk�lozun te�hisi i�in bile�ikler ve y�ntemler.
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228529A (en) * 1988-03-31 1991-07-26 Commw Scient Ind Res Org Diagnosis of mycobacterium bovis infection in a susceptible animal
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
FR2688785B1 (fr) * 1992-03-19 1995-07-07 Pasteur Institut Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.

Also Published As

Publication number Publication date
CA2110389A1 (fr) 1992-12-10
EP0589943A1 (de) 1994-04-06
FR2677365A1 (fr) 1992-12-11
DK0589943T3 (da) 2002-07-01
US5962240A (en) 1999-10-05
DE69232483D1 (de) 2002-04-18
ES2170055T3 (es) 2002-08-01
WO1992021758A1 (fr) 1992-12-10
US6060259A (en) 2000-05-09
FR2677365B1 (fr) 1995-08-04
DE69232483T2 (de) 2002-11-21
JPH06508513A (ja) 1994-09-29
EP0589943B1 (de) 2002-03-13

Similar Documents

Publication Publication Date Title
ATE214399T1 (de) Mycobacteriumprotein und dessen verwendung
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
NZ301290A (en) Mycobacterial proteins, micro-organisms producing same and vaccines thereof
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
ATE163195T1 (de) Lösliche liganden für cd40
EP0526544A4 (en) Therapeutic uses of actin-binding compounds
DK0770089T3 (da) Vækstdifferentieringsfaktor-12
DK0784703T3 (da) Lamininkæder: Diagnostisk og terapeutisk anvendelse
GR3022052T3 (en) Dna sequences which code for virulence characteristics of --(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by --(s. suis) in mammals, including man
DK0891340T3 (da) Oxazolderivater samt fremstilling og anvendelse deraf
DE69228749D1 (de) Neuartige polypeptide und ihre verwendung
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
DE69302375D1 (de) Kosmetische zusammensetzung zur erhaltung der frisur enthaltend ein milchprotein und/oder ein milchproteinhydrolysate und ein hydrolysate
DK0563144T3 (da) Diagnosticering af malign hypertermi hos svin
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
DK0403458T3 (da) Hidtil ukendte polypeptider og anvendelse deraf
NO890447L (no) Aminosyreamider med psykotrop virkning samt fremgangsmaater for fremstilling derav.
NO884110D0 (no) Nye aminosyreestere, samt fremgangsmaater for fremstilling derav.
EP1849800A3 (de) Moraxella catarrhalis-Proteine
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
DE69836226D1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
DK400089D0 (da) Genreguleringskassetter, ekspressionsvektorer indeholdende disse og mikroorganismer transformeret dermed
RU96112522A (ru) Способ отбора крупного рогатого скота на устойчивость к бруцеллезу

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee